nifedipine has been researched along with cgs 24012 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glashofer, M; Jacobson, KA; Jiang, Q; Lee, BX; van Rhee, AM | 1 |
Cox, BF; Kitzen, JM; Perrone, MH; Smits, GJ | 1 |
Schmidt, JT; Zhang, C | 1 |
3 other study(ies) available for nifedipine and cgs 24012
Article | Year |
---|---|
Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Affinity Labels; Animals; COS Cells; Enzyme-Linked Immunosorbent Assay; GTP-Binding Proteins; Humans; Hydrogen-Ion Concentration; Iodobenzenes; Ligands; Models, Chemical; Models, Molecular; Mutagenesis, Site-Directed; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Receptor, Adenosine A2A; Receptors, Biogenic Amine; Receptors, Purinergic P1; Structure-Activity Relationship; Xanthines | 1997 |
Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilation.
Topics: Adenosine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Nifedipine; Nitroglycerin; Rats; Rats, Sprague-Dawley; Tetrazoles; Vascular Resistance; Vasodilation | 1993 |
Adenosine A1 receptors mediate retinotectal presynaptic inhibition: uncoupling by C-kinase and role in LTP during regeneration.
Topics: Adenosine; Animals; Calcium; Enzyme Activation; Evoked Potentials, Visual; Goldfish; Long-Term Potentiation; Nerve Crush; Nerve Regeneration; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Optic Nerve; Optic Nerve Injuries; Peptides; Pertussis Toxin; Protein Kinase C; Receptors, Purinergic P1; Retina; Spider Venoms; Superior Colliculi; Synaptic Transmission; Virulence Factors, Bordetella; Visual Pathways; Xanthines | 1998 |